Discovery of CRN04894: A Novel Potent Selective MC2R Antagonist.

Saved in:
Bibliographic Details
Title: Discovery of CRN04894: A Novel Potent Selective MC2R Antagonist.
Authors: Kim SH; Crinetics Pharmaceuticals, Inc., 6055 Lusk Blvd., San Diego, California 92121, United States., Han S; Crinetics Pharmaceuticals, Inc., 6055 Lusk Blvd., San Diego, California 92121, United States., Zhao J; Crinetics Pharmaceuticals, Inc., 6055 Lusk Blvd., San Diego, California 92121, United States., Wang S; Crinetics Pharmaceuticals, Inc., 6055 Lusk Blvd., San Diego, California 92121, United States., Kusnetzow AK; Crinetics Pharmaceuticals, Inc., 6055 Lusk Blvd., San Diego, California 92121, United States., Reinhart G; Crinetics Pharmaceuticals, Inc., 6055 Lusk Blvd., San Diego, California 92121, United States., Fowler MA; Crinetics Pharmaceuticals, Inc., 6055 Lusk Blvd., San Diego, California 92121, United States., Markison S; Crinetics Pharmaceuticals, Inc., 6055 Lusk Blvd., San Diego, California 92121, United States., Johns M; Crinetics Pharmaceuticals, Inc., 6055 Lusk Blvd., San Diego, California 92121, United States., Luo R; Crinetics Pharmaceuticals, Inc., 6055 Lusk Blvd., San Diego, California 92121, United States., Struthers RS; Crinetics Pharmaceuticals, Inc., 6055 Lusk Blvd., San Diego, California 92121, United States., Zhu Y; Crinetics Pharmaceuticals, Inc., 6055 Lusk Blvd., San Diego, California 92121, United States., Betz SF; Crinetics Pharmaceuticals, Inc., 6055 Lusk Blvd., San Diego, California 92121, United States.
Source: ACS medicinal chemistry letters [ACS Med Chem Lett] 2024 Mar 19; Vol. 15 (4), pp. 478-485. Date of Electronic Publication: 2024 Mar 19 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first